Functional analyses demonstrated that VAV2 drives PCa proliferation and metastasis via the PAK1/AKT signaling pathway and promotes Enzalutamide resistance by stabilizing AR/ARv7 proteins through USP48 recruitment. The gene discussed is PAK1; the disease is posterior cortical atrophy.